According to a new market research report "Angiographic Catheters Marketby Application (Coronary, Endovascular, Neurology and Oncology), Geography (North America, Europe, Asia Pacific and Row), End-User Analysis (Reusage Scenario, Purchase Pattern) and Competitive Scenario - Global Forecast to 2022", the global market is projected to reach USD 1,402.8 Million by 2022 from USD 980.9 Million in 2017, at a CAGR of 7.4%.
Early buyers will receive 10% customization on this report
The Angiographic Catheters Market is primarily driven by the rising incidence of coronary artery diseases across the globe. Further, increasing demand for angiographic catheters in various applications such as chemoembolization, awareness regarding various diseases such as CVDs, and preference for minimally invasive surgeries are also driving the growth of this market.
Based on application, the coronary segment is projected to register the highest growth rate during the forecast period
Based on application, the market is segmented into coronary, endovascular, neurology, oncology and other applications (such as lungs, urology, and gastroenterology). The coronary segment is expected to grow at the highest CAGR during the forecast period. Factors driving the growth of this segment include the increasing incidence of cardiovascular disease, demand for catheter-based angiography in coronary treatments and awareness regarding various diseases mainly in developing countries.
Europe commanded the largest share of the market during the forecast period
Based on region, the Angiographic Catheters Market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). Europe dominated the Angiographic Catheters Market in 2017. This is mainly due to the large patient population throughout the region. The growing demand for minimally invasive surgeries is also driving the growth of this market
Key players operating in the Angiographic Catheters Market include Medtronic (US), Boston Scientific (US), Terumo Medical (Japan), Cardinal Health (US), and Merit Medical System (US).
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850-fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact: Mr. Salgarkar MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: 1-888-600-6441 [email protected]